These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 29016818)

  • 1. Posterior fossa syndrome and long-term neuropsychological outcomes among children treated for medulloblastoma on a multi-institutional, prospective study.
    Schreiber JE; Palmer SL; Conklin HM; Mabbott DJ; Swain MA; Bonner MJ; Chapieski ML; Huang L; Zhang H; Gajjar A
    Neuro Oncol; 2017 Nov; 19(12):1673-1682. PubMed ID: 29016818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma.
    Palmer SL; Hassall T; Evankovich K; Mabbott DJ; Bonner M; Deluca C; Cohn R; Fisher MJ; Morris EB; Broniscer A; Gajjar A
    Neuro Oncol; 2010 Dec; 12(12):1311-7. PubMed ID: 20713408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent cognitive dysfunction secondary to cerebellar injury in patients treated for posterior fossa tumors in childhood.
    Rønning C; Sundet K; Due-Tønnessen B; Lundar T; Helseth E
    Pediatr Neurosurg; 2005; 41(1):15-21. PubMed ID: 15886508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible association between the integrity of cerebellar pathways and neurocognitive performance in children with posterior fossa tumors.
    Liguoro I; Passone E; Zilli T; Maieron M; De Colle MC; Skrap M; Dolcemascolo V; Sommariva G; Cogo P; Tomasino B
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28538. PubMed ID: 32652734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of neuropsychological functioning in pediatric posterior fossa tumor survivors: Medulloblastoma, low-grade astrocytoma, and healthy controls.
    Levitch CF; Holland AA; Bledsoe J; Kim SY; Barnett M; Ramjan S; Sands SA
    Pediatr Blood Cancer; 2022 Feb; 69(2):e29491. PubMed ID: 34842359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early aging in adult survivors of childhood medulloblastoma: long-term neurocognitive, functional, and physical outcomes.
    Edelstein K; Spiegler BJ; Fung S; Panzarella T; Mabbott DJ; Jewitt N; D'Agostino NM; Mason WP; Bouffet E; Tabori U; Laperriere N; Hodgson DC
    Neuro Oncol; 2011 May; 13(5):536-45. PubMed ID: 21367970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral white matter fractional anisotropy and tract volume as measured by MR imaging are associated with impaired cognitive and motor function in pediatric posterior fossa tumor survivors.
    Rueckriegel SM; Bruhn H; Thomale UW; Hernáiz Driever P
    Pediatr Blood Cancer; 2015 Jul; 62(7):1252-8. PubMed ID: 25850573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processing speed, attention, and working memory after treatment for medulloblastoma: an international, prospective, and longitudinal study.
    Palmer SL; Armstrong C; Onar-Thomas A; Wu S; Wallace D; Bonner MJ; Schreiber J; Swain M; Chapieski L; Mabbott D; Knight S; Boyle R; Gajjar A
    J Clin Oncol; 2013 Oct; 31(28):3494-500. PubMed ID: 23980078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral white matter integrity and executive function in adult survivors of childhood medulloblastoma.
    Brinkman TM; Reddick WE; Luxton J; Glass JO; Sabin ND; Srivastava DK; Robison LL; Hudson MM; Krull KR
    Neuro Oncol; 2012 Sep; 14 Suppl 4(Suppl 4):iv25-36. PubMed ID: 23095827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological Profile in Children with Posterior Fossa Tumors with or Without Postoperative Cerebellar Mutism Syndrome (CMS).
    Cámara S; Fournier MC; Cordero P; Melero J; Robles F; Esteso B; Vara MT; Rodríguez S; Lassaletta Á; Budke M
    Cerebellum; 2020 Feb; 19(1):78-88. PubMed ID: 31832994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of risk factors for intellectual and academic outcomes following treatment for pediatric medulloblastoma.
    Schreiber JE; Gurney JG; Palmer SL; Bass JK; Wang M; Chen S; Zhang H; Swain M; Chapieski ML; Bonner MJ; Mabbott DJ; Knight SJ; Armstrong CL; Boyle R; Gajjar A
    Neuro Oncol; 2014 Aug; 16(8):1129-36. PubMed ID: 24497405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive, behavioral, and emotional outcomes following postoperative pediatric cerebellar mutism syndrome in survivors treated for medulloblastoma.
    Raghubar KP; Heitzer AM; Malbari F; Gill J; Sillitoe RV; Merrill L; Escalante J; Okcu MF; Aldave G; Meoded A; Kralik S; Davis K; Ma M; Warren EAH; McCurdy MD; Weiner HL; Whitehead W; Scheurer ME; Rodriguez L; Daigle A; Chintagumpala M; Kahalley LS
    J Neurosurg Pediatr; 2024 Jun; 33(6):516-523. PubMed ID: 38552237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive Function and Health-Related Quality of Life in Pediatric Korean Survivors of Medulloblastoma.
    Yoo HJ; Kim H; Park HJ; Kim DS; Ra YS; Shin HY
    J Korean Med Sci; 2016 Nov; 31(11):1726-1734. PubMed ID: 27709849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological functioning in survivors of childhood medulloblastoma/CNS-PNET: The role of secondary medical complications.
    Stadskleiv K; Stensvold E; Stokka K; Bechensteen AG; Brandal P
    Clin Neuropsychol; 2022 Apr; 36(3):600-625. PubMed ID: 32729777
    [No Abstract]   [Full Text] [Related]  

  • 15. Critical risk factors for intellectual impairment in children with posterior fossa tumors: the role of cerebellar damage.
    Grill J; Viguier D; Kieffer V; Bulteau C; Sainte-Rose C; Hartmann O; Kalifa C; Dellatolas G
    J Neurosurg; 2004 Nov; 101(2 Suppl):152-8. PubMed ID: 15835102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anesthesia Exposure during Therapy Predicts Neurocognitive Outcomes in Survivors of Childhood Medulloblastoma.
    Jacola LM; Anghelescu DL; Hall L; Russell K; Zhang H; Wang F; Peters JB; Rossi M; Schreiber JE; Gajjar A
    J Pediatr; 2020 Aug; 223():141-147.e4. PubMed ID: 32532646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Brain Substructure Dose and Cognitive Outcomes in Children With Medulloblastoma Treated on SJMB03: A Step Toward Substructure-Informed Planning.
    Acharya S; Guo Y; Patni T; Li Y; Wang C; Gargone M; Ashford JM; Wilson L; Faught A; Reddick WE; Patay Z; Gajjar A; Conklin HM; Merchant TE
    J Clin Oncol; 2022 Jan; 40(1):83-95. PubMed ID: 34714708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of neuropsychological outcomes following posterior fossa tumor surgery in children.
    Hanzlik E; Woodrome SE; Abdel-Baki M; Geller TJ; Elbabaa SK
    Childs Nerv Syst; 2015 Oct; 31(10):1869-75. PubMed ID: 26351236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal associations between exposure to anesthesia and neurocognitive functioning in pediatric medulloblastoma.
    Partanen M; Anghelescu DL; Hall L; Schreiber JE; Rossi M; Gajjar A; Jacola LM
    Eur J Cancer; 2021 May; 148():103-111. PubMed ID: 33743477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posterior fossa syndrome: Review of the behavioral and emotional aspects in pediatric cancer patients.
    Lanier JC; Abrams AN
    Cancer; 2017 Feb; 123(4):551-559. PubMed ID: 27787875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.